Market Overview

Global Defibrillator Market size was valued at around 7.29 billion in 2023 and is expected to reach a value of USD 14.45 billion by 2032, at a CAGR of 7.9% over the forecast period (2024–2032).

The growing prevalence of cardiovascular diseases, where patients finally come to understand how desperately a cardiac emergency needs medical treatment, has brought about this global market of defibrillators that are an important component of the health industry. Such devices are known as defibrillators; they are lifesaving machines, shocking or pulsing electricity through the heart in order to re-establish it into a normal rhythm. They are widely used in emergency medical services and hospitals as well as in public places for the treatment of sudden cardiac arrest, one of the main causes of death around the world. Medical technology advancement has propelled the development of sophisticated, portable, and relatively user-friendly defibrillators.

The key reason for market expansion is the upsurge of lifestyle diseases including diabetes, obesity, and hypertension, which enormously increase the incidence of heart ailments. Moreover, the ageing of the world's population makes more people prone to cardiovascular diseases; therefore, increased demand for the defibrillators is noticed. Another aspect that has contributed to the success of these devices is the government and private health care programs aimed at reducing deaths from a heart attack. Funds provided by the government, advertisement campaigns, and public installation of AEDs at arenas, schools, and airports have all been instrumental in catapulting growth in this industry.

Technology progress has been a central thrust in the development of the defibrillator market. Innovation in this direction- wearable defibrillators, wireless monitoring, and real-time analytics-data being integrated can make heart care more accessible as well as efficient. Artificial intelligence and machine learning are increasingly being used to analyse the performance of these systems, thus making way for the determination of personalized treatment plans and predictive diagnostics which promises to deliver better patient outcomes.

Furthermore, changes in consumers' preferences in the market require transportable and user-friendly defibrillators; therefore, its demand will rise because of a growing trend by non-medical professionals to use AEDs. Intuitive functionality and easy-to-use interfaces will support growth despite difficulties in high prices, strict regulations, and lack of awareness in developing countries.

Key Findings:

• In the U.S. 95% of sudden cardiac arrest victims die
• In a list of most common causes of death in the U.S. 1 of every 7.4 deaths were attributable to sudden cardiac arrest 4

Market Drivers

Growing prevalence of target diseases

• Cardiovascular diseases such as coronary artery disease and cardiac arrest affect a majority of the global population. Around the world, deaths are increasingly occurring due to the prevalence of cardiovascular diseases. According to the CDC, it is estimated that in 2021, CVD caused an estimated 695,000 deaths in the United States.
• Coronary artery disease increases the risk of sudden cardiac mortality from arrhythmias. In 2022, the Coronary Artery Disease Foundation estimated that nearly 356,000 out-of-hospital cardiac arrests (OHCA) occur annually in the United States. Lifestyle disorders such as obesity, diabetes, hypertension, and dyslipidaemia increase the risk for several cardiovascular disorders considerably. In addition, the growing number of elderly people worldwide is the primary cause for the increased prevalence of CVD. With the gradual deterioration in the heart's structure and function and an exponentially higher complexity of their structures, aging indeed faces exponential growth in ventricular arrhythmia development, thus causing a rise in the rate among the geriatric population. It is estimated that all these factors would lead to a surge in demand for defibrillators so that there is immediate device intervention in cases of cardiac emergencies.

Market Opportunities

Growing number of mergers & acquisitions among market players

• In order to enhance their product offerings internationally, major market participants in the defibrillator industry are slowly acquiring other companies. In doing so, producers of external and implantable defibrillators expand their product offerings for patients, enhance their technical efficiency, strengthen their financial base, and gain entry into new markets. While increasing cost pressures present challenges, acquisitions enable defibrillator manufacturers to maintain their margins and increase their global reach. Here are some of the most important mergers and acquisitions in the defibrillator market. In July 2020, ZOLL Medical, a subsidiary of Asahi Kasei, acquired Cardiac Science to strengthen its Critical Care business. This acquisition diversified the parent company's business line in the defibrillator and cardiac care space, giving it an edge over competitors.

Market Restraining Factors

Issues related to the use of implantable and automated external defibrillators

• Automated external defibrillators, or public access defibrillators, are often associated with technical issues that range from faulty hardware or batteries. Similarly, a number of complaints also list defective electronics, wiring, and connectors.
• These defects often fail the device from providing an electrical shock within a stipulated period. As such, when placing an order, public access locations or emergency service providers often select products from large, reputable firms that have shown consistent quality outputs. Thus, a major setback to the entry and expansion of new suppliers and regional distributors globally is the techno-commercial issues over ICDs and AEDs.

Segmentation Analysis

The market scope is segmented because of by Type, by patients’ type, by End Users.

• By Type

Based on the Type of the market is segmented into Implantable cardioverter defibrillators, Transvenous implantable cardioverter defibrillators, Subcutaneous implantable cardioverter defibrillators, External defibrillators, Manual & semi-automated external defibrillators, fully automated external defibrillators, Wearable cardioverter defibrillators.

The Implantable Cardioverter Defibrillators segment commanded the global market for defibrillators; these are extremely critical for handling potentially life-threatening cardiac arrhythmias and thereby preventing sudden death in such a high-risk individual. Among T-ICD, the existing efficacy, immense usage, and advanced functionalities placed them at top of the global market share under the ICD category. Since they are implanted into the body, monitor continuously with automated intervention when abnormal heart rhythms occur, T-ICDs are preferred in healthcare providers' treatment of a patient at risk of severe arrhythmia. Precise delivery of defibrillation therapy to the heart guarantees better outcomes that is why they are dominating.

The reasons for dominance by ICDs also lie in the fact that the incidence of cardiovascular diseases is increasing; the global population is aging, and patients as well as medical professionals are increasingly aware of the advantages of long-term cardiac rhythm management. Long-lasting battery life, better device miniaturization, and the capability to have remote monitoring all add to further growth in their market leadership.

While external defibrillators, including fully automated and wearable cardioverter defibrillators (WCDs), are gaining popularity, especially in public places and emergency situations, they mainly address the needs of immediate intervention. ICDs, especially T-ICDs, address a wider scope of long-term and preventive care applications, thus making them the leading type segment in the defibrillator market.

• By Patients type

Based on the Patients type of the market is segmented into Adult, Paediatrics.

The Adult segment led the world market for defibrillators, mainly on account of higher incidences of cardiovascular diseases and sudden cardiac arrests among adults. Adults, aged 40 years and above, are at significantly greater risk to heart-related diseases as a result of lifestyle diseases like obesity, hypertension, diabetes, and smoking. These risk factors are more prevalent in the adult population, which increases the need for defibrillators in this patient population.

The dominance of the adult segment can also be explained due to the extensive use of defibrillators by various professionals, including hospitals, emergency medical services, and public access locations. Adults make up the most common demographic for cardiac arrest in these locations. Moreover, ICDs and WCDs are significantly used for long-term heart rhythm disorder management; most of these patients are adults with a necessity to be treated for cardiac problems continuously.

Though the paediatric segment is a significant market as it deals with the needs of younger patients suffering from congenital or acquired heart conditions, the incidence rate of cardiac arrests and arrhythmias in children is relatively less than that of adults. Also, with improvement in adult-oriented defibrillator technologies and more awareness among people, along with the government taking measures to increase access to defibrillators, the adult segment has maintained its position as the largest segment in the market. This trend is likely to continue as the burden of cardiovascular diseases among adults increases globally.

• Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. Revenue in 2023 in North America stood at about 43.2% the highest due to various factors including developed healthcare infrastructure in the region, increasing the age population in that region, and high density of industry players as well as rising prevalence of heart diseases making the stakeholders and general public conscious about the technology accessible. For instance, based on the CDC, almost 695,000 people died of heart disease in 2021 in the United States alone, or 1 in 5 deaths. Over the period between 2018 and 2019, the U.S. had spent more than USD 239.9 billion. Technical advances and the growing rates of heart disorders are also due to the development of regional markets.

Asia Pacific is expected to rise significantly with numerous factors like sedentary lifestyles, poor eating habits, and ageing populations that raise the incidence of cardiovascular disease and increase demand for defibrillators and other effective treatment options. According to the "2022 Report on Global Burden of Cardiovascular Diseases and Risk Published," for instance, in December 2022, the high-income Asia Pacific area was reported to have the lowest age-standardized overall CVD mortality rate at 76.6 deaths per 1 lakh, while Central Asia's age-standardized overall CVD mortality rate was 516.9 deaths per 1 lakh. Due to the high prevalence of CVD, the number of interventional procedures in this region is growing, hence directly contributing to market growth.

List of Companies Profiled

• Medtronic
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• MicroPort Scientific Corporation
• Koninklijke Philips N.V.
• Stryker
• ZOLL Medical Corporation (Asahi Kasei)
• Nihon Kohden Corporation
• Schiller AG

Key Industry Developments

In February 2023, Medtronic (Ireland) received the CE Mark for its implantable defibrillator system, Aurora EV-ICD MRI SureScan, and Epsila EV MRI SureScan, both for the treatment of abnormal heart rhythm.

In January 2022, Koninklijke Philips N.V. acquired Cardiologs (France) to enhance the product portfolio for its cardiac diagnostic and monitoring product offerings.

In May 2021, To further expand the group's family of cardiac rhythm products, MicroPort Scientific Corporation (China) and Implicitly Inc. (US) enter a new distribution partnership.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Defibrillator Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Defibrillator Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Defibrillator market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Defibrillator. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Defibrillator companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Defibrillator Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Defibrillator Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Defibrillator Market valued?
• Which region has the largest share in 2024 for the global Defibrillator Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Defibrillator Market

• Historic year: 2019- 2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Billion

Defibrillator Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: